| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 347.14 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Since December 2013, the world has experienced the worst ever epidemic of Ebola virus disease (EVD), which has caused thousands of deaths in several West African countries. When the epidemic began, the European Union (EU) was not unprepared, thanks to the 10-year-long commitment of the European Commission (EC) to fund several networks in the area of highly infectious diseases. The European Network of Biosafety-Level 4 (BSL-4) laboratories (Euronet-P4, later called ENP4-Lab) was one of them; it has been operating since 2004, bringing together the facilities where RiskGroup 4 (RG-4) pathogens such as Ebola virus can be safely handled. In 2010, with the aim of increasing European preparedness in the fight against highly infectious trans-border threats, a new Joint Action was launched, resulting from the union of the networks that had previously worked on the diagnostics of highly infectious viruses and bacteria: ENP4-Lab and EQADeBa (Establishment of Quality Assurance for Detection of Highly Pathogenic Bacteria of Potential Bioterrorism Risk). (...)
Description
Keywords
Biosafety BSL-4 Ebola Virus Disease Emerging Diseases High Containment Laboratories Laboratory Networks Infecções Sistémicas e Zoonoses
Pedagogical Context
Citation
Clin Microbiol Infect. 2017 Feb;23(2):58-60. doi: 10.1016/j.cmi.2016.07.003. Epub 2016 Jul 9
Publisher
Elsevier/European Society of Clinical Microbiology and Infectious Diseases
